Clinical Trials Browser

Withdrawn × Locally Advanced Non-small Cell Lung Cancer × Immunotherapy × Clear all

NCT05481775 2022-11-21

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Locally Advanced Non-small Cell Lung Cancer